Evidence and Resources

The best outcomes start with evidence. And when evidence underpins policies and programs and is shared across borders and sectors, it can drive radical progress. 

Explore the latest resources on multiple micronutrient supplements (MMS) research, policy, and implementation below. 

  • Manufacturers

    Lomapharm

    Lomapharm August 2019

    Contract pharmaceutical manufacturer and developer in Germany known to manufacturer of MMS.

  • Manufacturers

    Contract Pharmacal Corp (CPC)

    CPCAugust 2019

    Contract pharmaceutical manufacturer and developer in the U.S. known to manufacturer of MMS.  

  • ImplementationManufacturersProduct Specifications

    UNIMMAP MMS Product Packaging Options, Cost, and Safety

    Kirk HumanitarianAugust 2019

    Infographic presenting the safety, financial, and environmental implications and availability of MMS depending on common packaging options. 

After 20 years of research and some 20 studies and meta-analyses comparing IFA and MMS on birth outcomes, it is unethical to further withhold MMS from pregnant women in low-resource settings.”

Klaus Kraemer, PhD, Sight and Life 

Learn more about our work and impact.

Learn about recommended MMS technical specifications.

X
Multiple Micronutrient Supplements for pregnant women are now included on the WHO Model List of Essential Medicines. Learn more about Halal-certified UNIMMAP MMS

here.